Literature DB >> 9593042

Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection.

J L Grogan1, P G Kremsner, A M Deelder, M Yazdanbakhsh.   

Abstract

Antigen-specific cellular immune responses were examined in persons previously infected with Schistosoma haematobium and who were, 2 years after chemotherapy, either free from infection (n = 17) or reinfected (n = 20). Proliferation to adult worm antigen (AWA) was significantly higher in uninfected than in reinfected subjects (P = .02), whereas responses to soluble egg antigen (SEA) remained low in both groups. Interleukin (IL)-5 production in uninfected persons in response to AWA and SEA was higher than in infected subjects (P = .05 and P < .001, respectively), while IL-4 and IL-13 release was similar in the 2 groups. Levels of interferon-gamma to AWA and to SEA were inversely correlated with egg output (P = .03 and P = .02, respectively). These data indicate that the presence of schistosome infection leads to T cell proliferative hyporesponsiveness and that both typical Th1 and Th2 cytokines can be down-regulated by active infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593042     DOI: 10.1086/517832

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes.

Authors:  V Rodrigues; K Piper; P Couissinier-Paris; O Bacelar; H Dessein; A J Dessein
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.

Authors:  J O Fleming; A Isaak; J E Lee; C C Luzzio; M D Carrithers; T D Cook; A S Field; J Boland; Z Fabry
Journal:  Mult Scler       Date:  2011-03-03       Impact factor: 6.312

Review 4.  Diversity and dialogue in immunity to helminths.

Authors:  Judith E Allen; Rick M Maizels
Journal:  Nat Rev Immunol       Date:  2011-06       Impact factor: 53.106

5.  Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Authors:  P W Mola; I O Farah; T M Kariuki; M Nyindo; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Infection outcome and cytokine gene expression in Brugia pahangi- infected gerbils (Meriones unguiculatus) sensitized with Brucella abortus.

Authors:  Sharon R Chirgwin; Philip H Elzer; Sharon U Coleman; Jena M Nowling; Sue D Hagius; Matthew D Edmonds; Thomas R Klei
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner.

Authors:  David Larson; Marc P Hübner; Marina N Torrero; Christopher P Morris; Amy Brankin; Brett E Swierczewski; Stephen J Davies; Becky M Vonakis; Edward Mitre
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

8.  Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children.

Authors:  Kirsten E Lyke; Alassane Dicko; Abdoulaye Dabo; Lansana Sangare; Abdoulaye Kone; Drissa Coulibaly; Ando Guindo; Karim Traore; Modibo Daou; Issa Diarra; Marcelo B Sztein; Christopher V Plowe; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2005-12       Impact factor: 2.345

9.  Chemokines in onchocerciasis patients after a single dose of ivermectin.

Authors:  J Fendt; D M Hamm; M Banla; H Schulz-Key; H Wolf; G Helling-Giese; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 10.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.